Ari Colosio speaks with Dr. Laura Garriga-Grimau about the first multi-country cohort study to describe the clinical features and standards of care for children and young people with bronchiectasis.

Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS.

Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies.

Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.

Dr. Ganesh Raghu discusses the highly anticipated results of the WRAP-IPF trial, borne out of debate surrounding the role of GER in the pathogenesis and progression of IPF, and conflicting findings from retrospective studies of antacid therapies on survival and disease progression.

Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.

Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.

Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.

Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.

Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension.